Chemours Co Stock Current Valuation
| CC Stock | USD 26.48 0.11 0.42% |
Valuation analysis of Chemours helps investors to measure Chemours' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Chemours' Enterprise Value Multiple is projected to increase significantly based on the last few years of reporting. Fundamental drivers impacting Chemours' valuation include:
Price Book 5.3492 | Enterprise Value 7 B | Enterprise Value Ebitda 35.7278 | Price Sales 0.6541 | Forward PE 6.9156 |
Undervalued
Today
Please note that Chemours' price fluctuation is not too volatile at this time. Calculation of the real value of Chemours is based on 3 months time horizon. Increasing Chemours' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Chemours Co is useful when determining the fair value of the Chemours stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Chemours. Since Chemours is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Chemours Stock. However, Chemours' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 26.48 | Real 29.92 | Target 37.89 | Hype 26.48 | Naive 24.77 |
The real value of Chemours Stock, also known as its intrinsic value, is the underlying worth of Chemours Company, which is reflected in its stock price. It is based on Chemours' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Chemours' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Chemours' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Chemours Co helps investors to forecast how Chemours stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Chemours more accurately as focusing exclusively on Chemours' fundamentals will not take into account other important factors: Chemours Co Company Current Valuation Analysis
Chemours' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Chemours Current Valuation | 7.02 B |
Most of Chemours' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Chemours Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Chemours Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for Chemours is extremely important. It helps to project a fair market value of Chemours Stock properly, considering its historical fundamentals such as Current Valuation. Since Chemours' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Chemours' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Chemours' interrelated accounts and indicators.
Click cells to compare fundamentals
Chemours Current Valuation Historical Pattern
Today, most investors in Chemours Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Chemours' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current valuation growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Chemours current valuation as a starting point in their analysis.
Chemours Current Valuation |
| Timeline |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Chemours Co has a Current Valuation of 7.02 B. This is 38.45% lower than that of the Chemicals sector and 77.21% lower than that of the Materials industry. The current valuation for all United States stocks is 57.76% higher than that of the company.
Chemours Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Chemours' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Chemours could also be used in its relative valuation, which is a method of valuing Chemours by comparing valuation metrics of similar companies.Chemours is currently under evaluation in current valuation category among related companies.
Chemours Current Valuation Drivers
We derive many important indicators used in calculating different scores of Chemours from analyzing Chemours' financial statements. These drivers represent accounts that assess Chemours' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemours' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 5.0B | 3.0B | 4.1B | 4.8B | 4.7B | 3.6B | |
| Enterprise Value | 7.8B | 6.4B | 7.3B | 7.5B | 7.2B | 5.3B |
Chemours Fundamentals
| Return On Equity | -0.26 | ||||
| Return On Asset | 0.0529 | ||||
| Profit Margin | (0.04) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 7.02 B | ||||
| Shares Outstanding | 148.88 M | ||||
| Shares Owned By Insiders | 0.59 % | ||||
| Shares Owned By Institutions | 76.90 % | ||||
| Number Of Shares Shorted | 4.88 M | ||||
| Price To Earning | 25.49 X | ||||
| Price To Book | 5.35 X | ||||
| Price To Sales | 0.65 X | ||||
| Revenue | 6.03 B | ||||
| Gross Profit | 1.62 B | ||||
| EBITDA | 220 M | ||||
| Net Income | (238 M) | ||||
| Cash And Equivalents | 1.1 B | ||||
| Cash Per Share | 7.73 X | ||||
| Total Debt | 4.3 B | ||||
| Debt To Equity | 2.94 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | 4.96 X | ||||
| Cash Flow From Operations | 556 M | ||||
| Short Ratio | 1.37 X | ||||
| Earnings Per Share | (1.60) X | ||||
| Price To Earnings To Growth | 1.67 X | ||||
| Target Price | 31.44 | ||||
| Number Of Employees | 6.2 K | ||||
| Beta | 2.02 | ||||
| Market Capitalization | 3.94 B | ||||
| Total Asset | 8.25 B | ||||
| Retained Earnings | 1.78 B | ||||
| Working Capital | 1.35 B | ||||
| Current Asset | 2.3 B | ||||
| Current Liabilities | 1.47 B | ||||
| Annual Yield | 0.04 % | ||||
| Five Year Return | 3.59 % | ||||
| Net Asset | 8.25 B | ||||
| Last Dividend Paid | 1.0 |
About Chemours Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemours Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Chemours
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.Moving against Chemours Stock
| 0.63 | DNMR | Danimer Scientific Financial Report 8th of May 2024 | PairCorr |
| 0.58 | ECL | Ecolab Inc Financial Report 7th of May 2024 | PairCorr |
| 0.55 | CMT | Core Molding Technologies Financial Report 14th of May 2024 | PairCorr |
| 0.51 | ASH | Ashland Global Holdings Financial Report 7th of May 2024 | PairCorr |
| 0.49 | CBT | Cabot Financial Report 13th of May 2024 | PairCorr |
The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.
The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Chemours Piotroski F Score and Chemours Altman Z Score analysis. Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Chemours Stock analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.91) | Dividend Share 1 | Earnings Share (1.60) | Revenue Per Share 40.473 | Quarterly Revenue Growth 0.017 |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.